E coli

Study suggests poor environmental controls may aid spread of resistant pathogens

The study found that E coli from people and meat products sold at markets in Cambodia contained resistance genes and mobile resistance elements that were strikingly similar.

Chris Dall

Impact of invasive E coli infections in older adults spotlighted

The vast majority of patients had community-onset invasive E coli (94%) and required hospitalization (97%), with 32% of patients needing ICU treatment.

Chris Dall

Study highlights resistance genes in Shiga toxin-producing E coli

Using long-read sequencing, the group found that 15% of E coli O157:H7 fecal samples harbored AMR genes.

Chris Dall

Salmonella outbreak tied to ground beef sickens people in 4 states

Patient interviews suggest ground beef bought from the same grocery chain, and an investigation into the source is underway.

Lisa Schnirring

Raw milk tied to Shiga toxin-producing E coli cases in Tennessee infants

Both infants were sick in the summer of 2022, and their households had received raw milk from the same cow-sharing arrangement.

Stephanie Soucheray

Study suggests E coli in meat could be causing urinary tract infections

Analysis of E coli from human infections and packaged meat suggested 8% of the clinical isolates originated in meat.

Chris Dall

Study suggests colistin still being widely used in animal feed

Low- and middle-income countries continue to import significant amounts of the last-resort antibiotic for growth promotion and disease prevention in food-producing animals.

Chris Dall

Multidrug-resistant E coli detected in Japanese wastewater

The study found more strains of multidrug-resistant E coli in municipal wastewater than in hospital wastewater.

Chris Dall

Resistance associated with higher mortality for E coli bloodstream infections

Though antimicrobial resistance was linked to increased mortality, patient characteristics also played a role.

Chris Dall

News Scan for Oct 10, 2022

Study finds boosters give good protection against Omicron hospital cases

A US study of almost 17,000 patients finds modest two-dose Pfizer COVID vaccine effectiveness (VE) against hospitalization and emergency department (ED) admission for Omicron BA.1 (the original Omicron variant) and the BA.2 subvariant, but three-dose VE was 79% and 71% for hospitalization, respectively, and 72% and 21% for ED visits.